47
Ensho Therapeutics, Inc. raises $20M under Reg D
Company raise · Pre-first close · Offering $20M · WOODCLIFF LAKE, NJ · filed 2026-02-09
47
Ensho Therapeutics raises $15.6M in biotech funding round
Company raise · Raising · WOODCLIFF LAKE, NJ · Form D filed 2026-10-15
Ensho Therapeutics, a Delaware biotech corporation incorporated in 2024, is raising $15.6M under Regulation D exemption 6(b). The company has sold $7.28M to 7 investors so far and is seeking an additional $8.32M.
$10M+ raiseoperating_company
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Danielle Fry | Executive Officer |
| Arash Rassoulpour | Director |
| Carlos Solorzano | Director |
| Eric Pham | Director |
| Gerhard Hagn | Director |
| Neena Bitritto-Garg | Director |
| Tariq Kassum | Director |
Signed by Danielle Fry, Chief Legal Officer & Chief Operating Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.
Other filings by this issuer
47
Ensho Therapeutics, Inc. raises $22.5M under Reg D
Company raise · Closed · Offering $22.5M · Sold $22.5M · MORRIS PLAINS, NY · filed 2025-09-12
52
Ensho Therapeutics, Inc. raises $5M under Reg D
Company raise · Raising · Offering $12.5M · Sold $5M · MORRIS PLAINS, NY · filed 2024-11-12